Multiple Sclerosis Clinical Trial
Official title:
Regulation of Lipid Metabolism in Autoimmune Disease: Multiple Sclerosis
The aim of this research is to understand how lipids such as cholesterol affect the disease process in people with MS.
In Multiple Sclerosis (MS) immune cells recognise myelin, the coating around nerve fibres, as
a foreign molecule and attack it by mistake; at the same time regulatory immune cells (which
are normally protective) do not work properly and cannot block the harmful effects of the
activated immune cells effectively.
Immune cells work via a complex system of signals that start on the outside layer of the cell
(the plasma membrane), these signals are transmitted inside the cell where they trigger
immune cell activation. The plasma membrane consists of a fatty layer and changes in the type
of fat in the membrane can affect immune cell signalling and immune cell function.
The aims of this project are to:
1. Identify what is different about the types of fat in immune cells from healthy donors
and people with MS and identify what triggers the production of these different types of
fat.
2. Identify how different types of fat control immune cell function in healthy donors and
people with MS
3. Identify possible ways to regulate the type of fat in immune cell membranes to restore
normal immune cell function in MS.
Methods: This research study involves collecting participant demographic and clinical
information, blood and Cerebral Spinal Fluid (CSF) (optional) from patients with MS. Blood
will also be collected from healthy volunteers for comparison. Experiments will be performed
on the blood samples and the results correlated with the clinical and disease features of
patients.
Outcomes: Many of the molecules involved in the generation of fats are well known and for
some of them drugs are already used in humans to treat diseases (for example statins). This
could allow the rapid translation of the results from this study to the clinic and have a
direct impact for people with MS.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05528666 -
Risk Perception in Multiple Sclerosis
|
||
| Completed |
NCT03608527 -
Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT05532943 -
Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis
|
Phase 1/Phase 2 | |
| Completed |
NCT02486640 -
Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
|
||
| Completed |
NCT01324232 -
Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT04546698 -
5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
|
||
| Active, not recruiting |
NCT04380220 -
Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
|
||
| Completed |
NCT02835677 -
Integrating Caregiver Support Into MS Care
|
N/A | |
| Completed |
NCT03686826 -
Feasibility and Reliability of Multimodal Evoked Potentials
|
||
| Recruiting |
NCT05964829 -
Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis
|
N/A | |
| Withdrawn |
NCT06021561 -
Orofacial Pain in Multiple Sclerosis
|
||
| Completed |
NCT03653585 -
Cortical Lesions in Patients With Multiple Sclerosis
|
||
| Recruiting |
NCT04798651 -
Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis
|
N/A | |
| Active, not recruiting |
NCT05054140 -
Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis
|
Phase 2 | |
| Completed |
NCT05447143 -
Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis
|
N/A | |
| Recruiting |
NCT06195644 -
Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients
|
Phase 1 | |
| Completed |
NCT04147052 -
iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis
|
N/A | |
| Completed |
NCT03591809 -
Combined Exercise Training in Patients With Multiple Sclerosis
|
N/A | |
| Completed |
NCT03594357 -
Cognitive Functions in Patients With Multiple Sclerosis
|
||
| Completed |
NCT03269175 -
BENEFIT 15 Long-term Follow-up Study of the BENEFIT and BENEFIT Follow-up Studies
|
Phase 4 |